Neuropsychiatric symptoms are early indicators of an upcoming metabolic decline in Alzheimer’s disease

BACKGROUND: Neuropsychiatric symptoms (NPS) are increasingly recognized as early non-cognitive manifestations in the Alzheimer’s disease (AD) continuum. However, the role of NPS as an early marker of pathophysiological progression in AD remains unclear. Dominantly inherited AD (DIAD) mutation carrie...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Transl Neurodegener
Main Authors: Ng, Kok Pin, Pascoal, Tharick A., Mathotaarachchi, Sulantha, Chan, Yiong Huak, Jiang, Lai, Therriault, Joseph, Benedet, Andrea L., Shin, Monica, Kandiah, Nagaendran, Greenwood, Celia M. T., Rosa-Neto, Pedro, Gauthier, Serge
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2021
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7780680/
https://ncbi.nlm.nih.gov/pubmed/33390174
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40035-020-00225-y
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados